FINAL - February 15, 2013

PURPOSE PRESIDER/PRESENTER(s)

8:00 Dr. Jonathan Temte (ACIP Chair)

Dr. Larry Pickering (Executive Secretary, ACIP)

8:30

8:45

· Introduction Dr. Nancy Bennett (ACIP, WG Chair)

Dr. Matthew Moore (CDC/NCIRD/DBD)

Ms. Tamara Pilishvili (CDC/NCIRD/DBD)

Vote Ms. Tamara Pilishvili (CDC/NCIRD/DBD)

VFC Vote Dr. Jeanne Santoli (CDC/NCIRD)

10:00

10:30

Dr. Lorry Rubin (ACIP, WG Chair)

Dr. Elizabeth Briere (CDC/NCIRD)

VFC Vote Dr. Jeanne Santoli (CDC/NCIRD)

11:30

Dr. Joseph Bocchini (ACIP, WG Chair)

Dr. Marc Fischer (CDC/NCEZID)

12:15

1:30

Dr. Mark Sawyer (ACIP, WG Chair)

Dr. Frank Destefano (CDC/NCEZID)

Dr. Thomas Clark (CDC/NCIRD)

3:15 Break

3:30 Information Dr. Lee Harrison (ACIP, WG Chair)

3:35 Information Dr. Jeanne Santoli (CDC/NCIRD)

3:45

· Introduction Dr. Jeff Duchin (ACIP, WG Chair)

· Special situations

5:00 Information Dr. Lisa Cairns (CDC/CGH/GID)

5:30 Information Dr. Robert Linkins (CDC/CGH/GID)

6:00 Public Comment

6:15 Adjourn

Japanese Encephalitis

Lunch

Measles and Rubella Initiative

· Update on immunization safety monitoring: Tdap 

administered to pregnant women 

· Pertussis in the United States and Tdap revaccination

Smallpox Vaccine Work Group

General Recommendations

· Timing and spacing of immunobiologics

· Contraindications and precautions

Pertussis Vaccines

Vaccine Supply

· Introduction

Global Polio Eradication Initiative

· Introduction

· Japanese encephalitis vaccine for U.S. travelers

Information & 

Discussion

Information & 

Discussion

Welcome & Introductions

Agency Updates

· Vaccines for Children: Hib-MenCY 

· Impact of PCV13 use in children

· PCV13 for children 6 through 18 years old with 

immunocompromising conditions: GRADE 

· PCV13 recommendations for children 6 through 18 years old 

with immunocompromising conditions

· Vaccines for Children

· Introduction

· Updated Hib Vaccine Recommendations

Information & 

Discussion

Information, 

Discussion & 

Vote

MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP)

Centers for Disease Control and Prevention

1600 Clifton Road, NE, Tom Harkin Global Communications Center (Building 19), Kent "Oz" Nelson Auditorium

Atlanta, Georgia 30333

February 20-21, 2013

AGENDA ITEM

Wednesday, February 20, 2013

Pneumococcal Vaccines

Haemophilus influenzae b (Hib) Vaccine

Break

· CDC, CMS, DoD, DVA, FDA, HRSA, IHS, NVPO, NIH

Dr. Andrew Kroger (CDC/NCIRD)

Information & 

Discussion

page 1 of 2
Final - February 15, 2013

8:00 Dr. Jonathan Temte (Chair, ACIP)

8:15 Information & 

Discussion

Dr. Ada Hinshaw* (Uniformed Services University 

of the Health Sciences, Bethesda, MD)

9:00

· Introduction Dr. Tamara Coyne-Beasley (ACIP, WG Chair) 

Dr. Carolyn Bridges (CDC/NCIRD)

Dr. Walter Williams (CDC/NCIRD)

Dr. Laura Hurley (University of Colorado)

Dr. Kris Sheedy (CDC/NCIRD)

Dr. Tamara Coyne-Beasley (ACIP, WG Chair) 

Dr. Carolyn Bridges (CDC/NCIRD)

10:15

10:45

· Introduction Dr.Wendy Keitel (ACIP, WG Chair)

Dr. Lyn Finelli (CDC/NCIRD)

· Vaccine Supply Dr. Jeanne Santoli (CDC/NCIRD)

Dr. Mark Thompson (CDC/NCIRD)

Dr. Lisa Dunkle (Protein Sciences)

Dr. Lisa Grohskopf (CDC/NCIRD)

Vote Dr. Lisa Grohskopf (CDC/NCIRD)

1:15 Public Comment

1:30 Adjourn

GRADE Grading of Recommendations Assessment, Development and Evaluation

NCEZID National Center for Emerging and Zoonotic Infectious Diseases

NCIRD National Center for Immunization and Respiratory Diseases

TBD To be determined

Tdap Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine

WG Work Group

· Consumer awareness regarding adult immunization 

· Discussion

· Proposed 2013-2014 recommendations

Thursday, February 21, 2013

Adult Immunization

IOM Immunization Schedule Report

· Provider survey results on adult immunization

* Chair, Committee on the Assessment of Health Outcomes Related to the Recommended Childhood Immunization Schedule, Institute of 

Medicine

Acronyms

· Upcoming topics

Information 

& 

Discussion

Information & 

Discussion

Unfinished Business

Break

· Updated adult immunization coverage

Influenza

· Vaccine effectiveness

· FluBlok

· Epidemiology and surveillance update

page 2 of 2